Baxter donates $2.5 million for patient
TORONTO – Baxter
Corporation has made a landmark investment of $2.5 million to support
the development of safer medical technologies at the Centre for Global
eHealth Innovation, based at University Health Network.
Baxter’s funding will support the Centre’s Human Healthcare Factors
Group, a team of elite researchers who design user-friendly and
supportive medical environments, processes, tools, and technologies. The
group’s goal is to make the healthcare system safer for everyone – a
mission they share with Baxter.
“At Baxter, we strive to develop products that help save and sustain
lives,” said Barbara M. Leavitt, President, Baxter Corporation. “We are
committed to pioneering innovation in healthcare for Canadians and are
working to bring the next generation of safer health technologies to
life through our investments in critical and innovative research.
“We are excited by the work currently under way by researchers at the
Centre for Global eHealth Innovation to develop technologies that will
help provide a safer healthcare environment for patients and
The funding received from Baxter, over 10 years, will establish the
Baxter Chair in Health Technology. Dr. Tony Easty (pictured), former
Senior Director of Medical Engineering at UHN, will be the inaugural
chairholder. Over the past 30 years, Dr. Easty has built a legacy of
exemplary leadership in the field of clinical engineering and was
instrumental in the creation of the Healthcare Human Factors Group.
“Baxter’s investment will fuel our team’s research into improving the
safety of health technologies in clinical use,” said Dr. Easty.
“Although safety research has been a high priority for many years in
industries such as aviation, its application to health technology is
recent. We need a better understanding of how errors occur, and what
steps can be taken to mitigate these errors.”
The Human Healthcare Factors Group is comprised of biomedical and human
factors engineers, cognitive psychologists, and healthcare providers,
and is the only such team in Canada. Their work to date has already
changed the approach that healthcare institutions are taking to the
implementation of safer medication delivery systems and this fall, they
will be announcing the results of a major study on improving the safety
of ambulatory intravenous chemotherapy in Canada.
About Baxter Corporation
As a subsidiary of Baxter International Inc., Baxter Corporation
manufactures and markets products that save and sustain the lives of
people with hemophilia, immune disorders, infectious diseases, kidney
disease, trauma and other chronic and acute medical conditions. As a
global, diversified healthcare company, Baxter applies a unique
combination of expertise in medical devices, pharmaceuticals and
biotechnology to create products that advance patient care worldwide.
For more information: www.baxter.ca.
About Toronto General & Western Hospital Foundation
Toronto General & Western Hospital Foundation raises funds for research,
education and the enhancement of patient care at Toronto General
Hospital and Toronto Western Hospital as well as for their respective
research arms, Toronto General Research Institute and Toronto Western
Research Institute. The Foundation’s vision is to enable global
leadership and innovation in health by developing and sustaining strong
relationships with University Health Network stakeholders. For more
About University Health Network
University Health Network consists of Toronto General, Toronto Western
and Princess Margaret Hospitals. The scope of research and complexity of
cases at University Health Network has made it a national and
international source for discovery, education and patient care. It has
the largest hospital-based research program in Canada, with major
research in cardiology, transplantation, neurosciences, oncology,
surgical innovation, infectious diseases, and genomic medicine.
University Health Network is a research hospital affiliated with the
University of Toronto. For more information:
Posted October 7, 2010